- Home
- PERF vs KROS Comparison
PERF vs KROS Comparison
Compare PERF & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PERF | KROS |
|---|---|---|
| Founded | 2015 | 2015 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.6M | 206.0M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | PERF | KROS |
|---|---|---|
| Price | $1.94 | $11.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.86 |
| AVG Volume (30 Days) | ★ 155.9K | 155.0K |
| Earning Date | 04-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $243,864,000.00 |
| Revenue This Year | $12.93 | N/A |
| Revenue Next Year | $9.44 | $2,751.79 |
| P/E Ratio | $26.42 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.24 | $9.69 |
| 52 Week High | $2.15 | $22.55 |
Technical Indicators
Market Signals| Indicator | PERF | KROS |
|---|---|---|
| Relative Strength Index (RSI) | 62.77 | 53.55 |
| Support Level | $1.92 | $10.57 |
| Resistance Level | $1.94 | $11.56 |
| Average True Range (ATR) | 0.03 | 0.45 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 73.53 | 50.81 |
Price Performance
Historical ComparisonAbout PERF Perfect Corp.
Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.